{"created":"2023-06-19T09:51:45.994204+00:00","id":9049,"links":{},"metadata":{"_buckets":{"deposit":"5393945b-386b-4efb-846e-823bd4232110"},"_deposit":{"created_by":18,"id":"9049","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"9049"},"status":"published"},"_oai":{"id":"oai:fukuyama-u.repo.nii.ac.jp:00009049","sets":["502:503:627:802"]},"author_link":["46655","45524"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"37","bibliographicPageEnd":"48","bibliographicPageStart":"48","bibliographic_titles":[{"bibliographic_title":"福山大学薬学部研究年報"},{"bibliographic_title":"Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University","bibliographic_titleLang":"en"}]}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"福山大学薬学部"}]},"item_10002_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN10064550","subitem_source_identifier_type":"NCID"}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0288724X","subitem_source_identifier_type":"ISSN"}]},"item_10002_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"今, 重之"}],"nameIdentifiers":[{"nameIdentifier":"45524","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"上出, 利光"}],"nameIdentifiers":[{"nameIdentifier":"46655","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-04-14"}],"displaytype":"detail","filename":"48 福山大学薬学部研究年報第37号.pdf","filesize":[{"value":"807.5 kB"}],"format":"application/pdf","license_note":"Copyright(c)2019 by Fukuyama University\n","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"48 福山大学薬学部研究年報第37号","url":"https://fukuyama-u.repo.nii.ac.jp/record/9049/files/48 福山大学薬学部研究年報第37号.pdf"},"version_id":"e2932034-6373-4626-bb0f-7fbe46694bac"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"自己免疫疾患増悪化におけるα 9 β 1 インテグリンの役割","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"自己免疫疾患増悪化におけるα 9 β 1 インテグリンの役割"},{"subitem_title":"The role of α9β1 integrin and its ligands in the development of autoimmune diseases.","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"18","path":["802"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-04-14"},"publish_date":"2021-04-14","publish_status":"0","recid":"9049","relation_version_is_last":true,"title":["自己免疫疾患増悪化におけるα 9 β 1 インテグリンの役割"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-06-19T10:09:47.361720+00:00"}